×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MLTX – moonlake immunotherapeutics - class a ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MLTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/2
11:54 am
mltx
MoonLake Immunotherapeutics (MLTX) had its price target raised by Royal Bank Of Canada from $12.00 to $13.00. They now have a "sector perform" rating on the stock.
Neutral
Report
MoonLake Immunotherapeutics (MLTX) had its price target raised by Royal Bank Of Canada from $12.00 to $13.00. They now have a "sector perform" rating on the stock.
3/2
10:38 am
mltx
Goldman Questions MoonLake Immunotherapeutics' (MLTX) Sonelokimab Approval Odds Despite Pipeline Update [Yahoo! Finance]
Low
Report
Goldman Questions MoonLake Immunotherapeutics' (MLTX) Sonelokimab Approval Odds Despite Pipeline Update [Yahoo! Finance]
3/2
08:43 am
mltx
MoonLake Immunotherapeutics (MLTX) had its price target raised by HC Wainwright from $32.00 to $40.00. They now have a "buy" rating on the stock.
Medium
Report
MoonLake Immunotherapeutics (MLTX) had its price target raised by HC Wainwright from $32.00 to $40.00. They now have a "buy" rating on the stock.
2/26
06:28 am
mltx
MoonLake Immunotherapeutics (MLTX) was upgraded by Zacks Research from "strong sell" to "hold".
Low
Report
MoonLake Immunotherapeutics (MLTX) was upgraded by Zacks Research from "strong sell" to "hold".
2/24
08:02 am
mltx
MoonLake Immunotherapeutics (NASDAQ:MLTX) had its price target raised by analysts at BTIG Research from $24.00 to $30.00. They now have a "buy" rating on the stock.
Medium
Report
MoonLake Immunotherapeutics (NASDAQ:MLTX) had its price target raised by analysts at BTIG Research from $24.00 to $30.00. They now have a "buy" rating on the stock.
2/24
08:02 am
mltx
MoonLake Immunotherapeutics (NASDAQ:MLTX) had its price target raised by analysts at Needham & Company LLC from $20.00 to $25.00. They now have a "buy" rating on the stock.
Medium
Report
MoonLake Immunotherapeutics (NASDAQ:MLTX) had its price target raised by analysts at Needham & Company LLC from $20.00 to $25.00. They now have a "buy" rating on the stock.
2/24
08:02 am
mltx
MoonLake Immunotherapeutics (NASDAQ:MLTX) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Medium
Report
MoonLake Immunotherapeutics (NASDAQ:MLTX) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
2/22
11:00 am
mltx
MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results
Low
Report
MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results
Date
Time
Symbol
Company Name
Action
%Chg
2/25/2026
06:12 am
mltx
moonlake immunotherapeutics - class a ordinary shares
MISS
Report
0.9%
moonlake immunotherapeutics - class a ordinary shares
11/5/2025
07:00 am
mltx
moonlake immunotherapeutics - class a ordinary shares
MISS
Report
4.7%
moonlake immunotherapeutics - class a ordinary shares
8/5/2025
07:00 am
mltx
moonlake immunotherapeutics - class a ordinary shares
MISS
Report
1.5%
moonlake immunotherapeutics - class a ordinary shares
5/12/2025
04:00 pm
mltx
moonlake immunotherapeutics - class a ordinary shares
BEAT
Report
-4.1%
moonlake immunotherapeutics - class a ordinary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
2/24
08:02 am
Reiterates
Outperform
Outperform
Oppenheimer Holdings, Inc.
Medium
Report
-3.0%
Date
Time
Symbol
Headline
Impact
2/25
06:13 am
mltx
Form 10-K MoonLake Immunotherapeut For: Dec 31
Low
Report
Form 10-K MoonLake Immunotherapeut For: Dec 31
2/23
06:05 am
mltx
Form 8-K MoonLake Immunotherapeut For: Feb 18
Medium
Report
Form 8-K MoonLake Immunotherapeut For: Feb 18
2/17
03:02 pm
mltx
Form SCHEDULE 13G MoonLake Immunotherapeut Filed by: Cormorant Asset Management, LP
Low
Report
Form SCHEDULE 13G MoonLake Immunotherapeut Filed by: Cormorant Asset Management, LP
1/9
04:01 pm
mltx
Form 4 MoonLake Immunotherapeut For: Jan 07 Filed by: Reich Kristian
Medium
Report
Form 4 MoonLake Immunotherapeut For: Jan 07 Filed by: Reich Kristian
1/9
04:01 pm
mltx
Form 4 MoonLake Immunotherapeut For: Jan 07 Filed by: Bodenstedt Matthias
Medium
Report
Form 4 MoonLake Immunotherapeut For: Jan 07 Filed by: Bodenstedt Matthias
1/9
04:01 pm
mltx
Form 4 MoonLake Immunotherapeut For: Jan 07 Filed by: Santos da Silva Jorge
Medium
Report
Form 4 MoonLake Immunotherapeut For: Jan 07 Filed by: Santos da Silva Jorge
1/8
08:01 am
mltx
Form 8-K MoonLake Immunotherapeut For: Jan 08
Low
Report
Form 8-K MoonLake Immunotherapeut For: Jan 08
12/22
04:02 pm
mltx
Form 4 MoonLake Immunotherapeut For: Dec 19 Filed by: Reich Kristian
Low
Report
Form 4 MoonLake Immunotherapeut For: Dec 19 Filed by: Reich Kristian
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: